Cargando…
Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate l-pipecolic acid in Escherichia coli
BACKGROUND: The six-carbon circular non-proteinogenic compound l-pipecolic acid is an important chiral drug intermediate with many applications in the pharmaceutical industry. In the present study, we developed a metabolically engineered strain of Escherichia coli for the overproduction of l-pipecol...
Autores principales: | Ying, Hanxiao, Tao, Sha, Wang, Jing, Ma, Weichao, Chen, Kequan, Wang, Xin, Ouyang, Pingkai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369227/ https://www.ncbi.nlm.nih.gov/pubmed/28347340 http://dx.doi.org/10.1186/s12934-017-0666-0 |
Ejemplares similares
-
A Novel Process for Cadaverine Bio-Production Using a Consortium of Two Engineered Escherichia coli
por: Wang, Jing, et al.
Publicado: (2018) -
Regulation of ATP levels in Escherichia coli using CRISPR interference for enhanced pinocembrin production
por: Tao, Sha, et al.
Publicado: (2018) -
The Biosynthesis of D-1,2,4-Butanetriol From d-Arabinose With an Engineered Escherichia coli
por: Wang, Jing, et al.
Publicado: (2022) -
Enhanced pinocembrin production in Escherichia coli by regulating cinnamic acid metabolism
por: Cao, Weijia, et al.
Publicado: (2016) -
Engineering a pyridoxal 5’-phosphate supply for cadaverine production by using Escherichia coli whole-cell biocatalysis
por: Ma, Weichao, et al.
Publicado: (2015)